Bliss GVS Pharma

Market Cap

1,307.17 Cr

EPS

7.23

PE Ratio

16.10

Dividend Yield

0.40 %

Industry

Healthcare

52 Week High

185.50

52 Week Low

92.15

PB Ratio

1.28

Debt to Equity

0.11

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,764.75	4,23,422.64	36.32	49,887.20	12.06	9,648	13.77	61.58
Divis Laboratories	5,840.65	1,55,050.91	75.90	8,184.00	0.89	1,600	64.53	55.23
Cipla	1,511.20	1,22,046.63	24.67	26,520.70	14.17	4,155	47.38	60.28
Torrent Pharmaceuticals	3,245.05	1,09,827.24	59.25	10,785.70	11.59	1,656	13.54	61.68
Mankind Pharma	2,398.05	98,935.61	47.95	10,615.60	19.57	1,942	-16.38	56.07
Dr Reddys Laboratories	1,177.90	98,285.26	18.80	28,905.40	12.36	5,578	1.69	51.86
Lupin	2,068.75	94,375.87	33.76	20,141.50	19.94	1,936	38.82	54.50
Zydus Life Science	907.35	91,300.64	20.56	19,831.50	13.82	3,831	29.92	48.54
Aurobindo Pharma	1,194.95	69,402.89	19.93	29,559.20	17.55	3,169	-10.04	61.05
Abbott	31,101.85	66,089.26	49.48	6,097.20	10.80	1,201	16.01	61.04

Growth Rate

Revenue Growth

3.85 %

Net Income Growth

6.39 %

Cash Flow Change

344.33 %

ROE

-2.75 %

ROCE

-2.81 %

EBITDA Margin (Avg.)

27.85 %

Quarterly Financial Results

Quarterly Financials	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	100	184	138	148	146	162	235	241	226	239	198	173	219	253	217	247	214	223	153	139	137	154	168	138	176	201	222	179	196	175	211	188	165	225	206	204	188	223	226
Expenses	60	132	104	95	101	126	187	182	161	179	148	164	165	187	177	212	163	185	115	117	110	120	126	115	134	167	256	147	150	148	158	179	135	158	157	199	149	176	181
EBITDA	40	51	34	52	46	36	48	60	65	61	50	9	55	66	40	35	51	38	39	21	27	35	42	23	42	35	-33	32	46	27	53	9	29	67	49	5	39	47	45
Operating Profit %	36 %	25 %	21 %	34 %	27 %	21 %	18 %	27 %	28 %	20 %	25 %	2 %	20 %	18 %	20 %	13 %	23 %	12 %	22 %	2 %	15 %	21 %	23 %	13 %	21 %	15 %	-18 %	12 %	21 %	14 %	23 %	3 %	15 %	26 %	22 %	-0 %	19 %	19 %	14 %
Depreciation	3	6	3	2	4	4	11	1	5	5	7	5	2	2	2	2	3	4	3	3	4	4	4	4	4	4	4	4	5	5	5	5	6	6	7	7	7	7	8
Interest	5	5	2	7	4	4	4	8	7	6	5	5	1	1	1	1	1	1	1	5	2	0	1	2	1	1	1	2	2	2	1	5	2	2	2	2	2	4	1
Profit Before Tax	33	41	31	43	41	36	38	60	56	52	39	-1	51	63	37	32	47	34	34	13	20	30	37	17	37	30	-39	27	39	20	47	-1	22	59	40	-4	30	36	36
Tax	13	13	7	15	13	15	17	18	19	12	13	12	12	21	9	13	14	3	9	8	4	8	10	8	11	8	10	3	12	4	18	-4	7	16	11	1	8	10	11
Net Profit	20	28	24	29	28	21	22	43	37	40	26	-14	39	42	27	19	33	31	26	6	17	22	28	8	26	22	-49	24	28	16	30	4	14	43	29	-5	22	26	26
EPS in ₹	1.89	2.23	2.15	1.71	2.67	2.46	2.02	3.21	2.05	4.93	1.74	-1.39	3.72	4.02	2.50	1.76	3.28	3.00	2.30	0.85	1.57	1.99	2.48	0.61	2.35	2.05	-4.83	1.90	2.48	1.33	2.68	0.34	1.41	4.06	2.64	-0.88	1.97	2.31	2.27

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	662	762	1,023	860	905	1,027	1,077	1,109	1,157	1,214
Fixed Assets	234	225	305	143	146	242	234	282	379	370
Current Assets	417	471	566	690	694	770	765	777	697	812
Capital Work in Progress	0	9	4	1	47	0	2	22	3	8
Investments	0	0	0	0	0	0	0	2	8	4
Other Assets	428	527	714	717	712	786	840	803	768	832
Total Liabilities	662	762	1,023	860	905	1,027	1,077	1,109	1,157	1,214
Current Liabilities	243	267	437	299	207	231	204	233	193	160
Non Current Liabilities	68	50	33	13	38	46	45	29	46	51
Total Equity	352	446	553	548	660	750	828	847	917	1,003
Reserve & Surplus	327	402	476	526	636	725	798	808	874	957
Share Capital	10	10	10	10	10	10	10	10	10	11

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-34	23	30	-11	-22	0	-2	9	3	-1
Investing Activities	-30	-50	-249	48	-79	-40	-45	-103	-6	-133
Operating Activities	38	113	290	18	40	47	64	136	34	152
Financing Activities	-42	-40	-10	-76	17	-6	-21	-24	-25	-21

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	33.31 %	33.24 %	33.19 %	33.14 %	33.14 %	34.51 %	34.55 %	34.46 %	35.04 %	35.12 %	35.06 %	34.97 %	34.97 %	34.90 %	34.82 %	35.10 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	16.31 %	0.00 %	14.73 %	13.25 %	12.13 %	13.51 %
DIIs	6.72 %	6.72 %	6.67 %	6.66 %	6.66 %	6.65 %	6.64 %	6.63 %	6.63 %	6.62 %	6.61 %	6.59 %	6.59 %	6.58 %	6.57 %	6.55 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	23.45 %	26.90 %	27.59 %	28.26 %	30.37 %	30.15 %	30.57 %	30.74 %	30.00 %	30.10 %	29.17 %	30.78 %	31.71 %	32.84 %	34.57 %	32.93 %
Others	36.52 %	33.14 %	32.55 %	31.95 %	29.84 %	28.69 %	28.24 %	28.18 %	28.33 %	28.15 %	12.84 %	27.66 %	12.00 %	12.43 %	11.92 %	11.91 %
No of Share Holders	28,543	39,999	42,742	41,080	45,866	46,327	45,753	44,983	43,041	42,182	43,234	40,758	45,157	44,737	52,937	49,558